BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial aiming to evaluate the safety and clinical performance of its new-generation resorbable magnesium scaffold (RMS), Freesolve™, compared to a contemporary drug-eluting stent (DES). "We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the implantation results of the Freesolve resorbable magnesium scaffold," said Dr. Juan F. Iglesias, HUG - University Hospital Geneva in Switzerland. "Resorbable scaffolds have shown potential in reducing long-term adverse events compared to DES, marking a significant advancement in vascular intervention. We finally have a scaffold that delivers on its promise." The BIOMAG-II trial is a prospective, international multi-center randomized-controlled study spanning 21 countries across Europe and the Asia-Pacific region
PTA (Peripheral Transluminal Angioplasty) balloon catheters are minimally invasive devices indicated to dilate stenoses in various peripheral arteries afflicted with peripheral artery disease (PAD). PTA balloons are designed to be inflated to their indicated diameter to restore blood flow in blocked arteries.
Peripheral vascular intervention (PVI), also known as peripheral artery intervention, encompasses a variety of different minimally invasive percutaneous procedures used to treat peripheral artery disease (PAD). PAD is a condition in which the arteries outside the heart, typically in the legs and feet, become narrowed or blocked usually due to the buildup of plaque. PVI aims to restore blood flow in these peripheral arteries, relieve symptoms, and prevent complications.
Indicated for use in patients with atherosclerotic disease of the femoral and infrapopliteal arteries and for the treatment of insufficient results after Percutaneous Transluminal Angioplasty(PTA).*
Coronary drug-coated balloon catheters are used for the treatment of coronary arteries with simultaneous release of an anti-proliferative drug to the vessel wall.
The all-in-one solution to reach, cross and prepare lesions.1 One Solution: Multiple functions. Simplify your approach to a complex problem. Oscar Peripheral Multifunctional Catheter is indicated for percutaneous transluminal interventions in the peripheral vasculature to provide support during access into and to dilate stenoses in femoral, popliteal and infrapopliteal arteries. The product is also intended for injection of radiopaque contrast media for the purpose of angiography.1
Indicated for improving arterial luminal diameter in patients with clinical symptoms attributable to atherosclerotic stenosis of the renal arteries.*
Guidion Hydro guide extension catheter has a radiopaque soft tip for true distal end visibility facilitating precise device positioning. The high density coiling of the distal shaft ensures optimal lumen integrity and smooth device delivery. A proximal oval push rod design keeps the profile low while securing optimal pushability.1
